Amsterdam inherits European Medicines Agency from London

OLIVIER HOSLET

Illustration of the closed European parliament as Session is Taking place at Strasbourg, in Brussels, Belgium, 04 July 2017. During this session of the European parliament, a discussion regarding the opportunity to make all plenary session with only one seat in Brussels and change the European Parliament seat in Strasbourg to the European Medicines Agency (EMA).

Amsterdam inherits European Medicines Agency from London


Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+

The European Council picked Amsterdam as the new seat of the European Medicines Agency.

In the first round of voting, Amsterdam was behind Milan but ahead of Copenhagen, ANSA agency reported.

In the second round there was an equal amount of votes and the decision was taken by a “coin toss.” The Estonian Presidency in fact used two little envelopes rather than an actual coin. 

The EMA will now move to Amsterdam within the next 17 months.

Among the criteria for the choice were the premises for the agency on offer, accessibility of location, education facilities for the children of the staff, access to the labour market for children and spouses, and business continuity.

The EMA will lose 20% of its workforce as it leaves London and sheds UK employees, mostly in the field of regulatory experts and legal consultants with scientific and policy expertise.

Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+